Logo image of MTAL

MAC COPPER LTD (MTAL) Stock Fundamental Analysis

USA - NYSE:MTAL - JE00BQBC8469 - Common Stock

12.21 USD
0 (0%)
Last: 10/7/2025, 7:44:34 PM
12.21 USD
0 (0%)
After Hours: 10/7/2025, 7:44:34 PM
Fundamental Rating

3

MTAL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 156 industry peers in the Metals & Mining industry. MTAL may be in some trouble as it scores bad on both profitability and health. MTAL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year MTAL has reported negative net income.
MTAL had a positive operating cash flow in the past year.
MTAL had negative earnings in 4 of the past 5 years.
MTAL had negative operating cash flow in 4 of the past 5 years.
MTAL Yearly Net Income VS EBIT VS OCF VS FCFMTAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.05%, MTAL is doing worse than 64.74% of the companies in the same industry.
MTAL has a worse Return On Equity (-17.03%) than 69.23% of its industry peers.
The Return On Invested Capital of MTAL (5.65%) is better than 65.38% of its industry peers.
Industry RankSector Rank
ROA -6.05%
ROE -17.03%
ROIC 5.65%
ROA(3y)-6.21%
ROA(5y)N/A
ROE(3y)-23.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MTAL Yearly ROA, ROE, ROICMTAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30 -40 -50

1.3 Margins

With a decent Operating Margin value of 22.68%, MTAL is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Looking at the Gross Margin, with a value of 31.07%, MTAL is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
OM 22.68%
PM (TTM) N/A
GM 31.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MTAL Yearly Profit, Operating, Gross MarginsMTAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MTAL is destroying value.
MTAL has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, MTAL has an improved debt to assets ratio.
MTAL Yearly Shares OutstandingMTAL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
MTAL Yearly Total Debt VS Total AssetsMTAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 500M 1B

2.2 Solvency

Based on the Altman-Z score of 0.70, we must say that MTAL is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.70, MTAL is doing worse than 85.26% of the companies in the same industry.
The Debt to FCF ratio of MTAL is 7.26, which is on the high side as it means it would take MTAL, 7.26 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.26, MTAL is in the better half of the industry, outperforming 66.03% of the companies in the same industry.
A Debt/Equity ratio of 0.68 indicates that MTAL is somewhat dependend on debt financing.
MTAL has a Debt to Equity ratio of 0.68. This is amonst the worse of the industry: MTAL underperforms 82.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 7.26
Altman-Z 0.7
ROIC/WACC0.55
WACC10.24%
MTAL Yearly LT Debt VS Equity VS FCFMTAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 0.58 indicates that MTAL may have some problems paying its short term obligations.
MTAL's Current ratio of 0.58 is on the low side compared to the rest of the industry. MTAL is outperformed by 92.31% of its industry peers.
A Quick Ratio of 0.45 indicates that MTAL may have some problems paying its short term obligations.
MTAL has a Quick ratio of 0.45. This is amonst the worse of the industry: MTAL underperforms 91.03% of its industry peers.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.45
MTAL Yearly Current Assets VS Current LiabilitesMTAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M 200M 250M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 65.56% over the past year.
MTAL shows a strong growth in Revenue. In the last year, the Revenue has grown by 114.30%.
EPS 1Y (TTM)65.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.27%
Revenue 1Y (TTM)114.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.39%

3.2 Future

MTAL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 89.23% yearly.
Based on estimates for the next years, MTAL will show a quite strong growth in Revenue. The Revenue will grow by 12.12% on average per year.
EPS Next Y270.09%
EPS Next 2Y183.08%
EPS Next 3Y104.94%
EPS Next 5Y89.23%
Revenue Next Year6.2%
Revenue Next 2Y15.2%
Revenue Next 3Y12.29%
Revenue Next 5Y12.12%

3.3 Evolution

MTAL Yearly Revenue VS EstimatesMTAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
MTAL Yearly EPS VS EstimatesMTAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 0 1 -1 2

6

4. Valuation

4.1 Price/Earnings Ratio

MTAL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
MTAL is valuated reasonably with a Price/Forward Earnings ratio of 10.66.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MTAL indicates a rather cheap valuation: MTAL is cheaper than 82.69% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of MTAL to the average of the S&P500 Index (23.21), we can say MTAL is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 10.66
MTAL Price Earnings VS Forward Price EarningsMTAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

MTAL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MTAL is cheaper than 83.97% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MTAL indicates a rather cheap valuation: MTAL is cheaper than 86.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.49
EV/EBITDA 8.18
MTAL Per share dataMTAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MTAL's earnings are expected to grow with 104.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y183.08%
EPS Next 3Y104.94%

0

5. Dividend

5.1 Amount

No dividends for MTAL!.
Industry RankSector Rank
Dividend Yield N/A

MAC COPPER LTD

NYSE:MTAL (10/7/2025, 7:44:34 PM)

After market: 12.21 0 (0%)

12.21

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)10-20 2025-10-20/bmo
Inst Owners35.58%
Inst Owner Change0%
Ins Owners0.31%
Ins Owner ChangeN/A
Market Cap1.01B
Analysts77.78
Price Target12.5 (2.38%)
Short Float %1.84%
Short Ratio1.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-17.99%
PT rev (3m)-17.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-23.59%
EPS NY rev (1m)-51.89%
EPS NY rev (3m)-51.53%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-3.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.66
P/S 2.95
P/FCF 19.49
P/OCF 8.32
P/B 2.1
P/tB 2.1
EV/EBITDA 8.18
EPS(TTM)-0.99
EYN/A
EPS(NY)1.14
Fwd EY9.38%
FCF(TTM)0.63
FCFY5.13%
OCF(TTM)1.47
OCFY12.01%
SpS4.13
BVpS5.82
TBVpS5.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.05%
ROE -17.03%
ROCE 7.16%
ROIC 5.65%
ROICexc 6.28%
ROICexgc 6.28%
OM 22.68%
PM (TTM) N/A
GM 31.07%
FCFM 15.16%
ROA(3y)-6.21%
ROA(5y)N/A
ROE(3y)-23.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 7.26
Debt/EBITDA 2.11
Cap/Depr 88.98%
Cap/Sales 20.34%
Interest Coverage 1.86
Cash Conversion 77.97%
Profit Quality N/A
Current Ratio 0.58
Quick Ratio 0.45
Altman-Z 0.7
F-Score6
WACC10.24%
ROIC/WACC0.55
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.27%
EPS Next Y270.09%
EPS Next 2Y183.08%
EPS Next 3Y104.94%
EPS Next 5Y89.23%
Revenue 1Y (TTM)114.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.39%
Revenue Next Year6.2%
Revenue Next 2Y15.2%
Revenue Next 3Y12.29%
Revenue Next 5Y12.12%
EBIT growth 1Y660.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year134.05%
EBIT Next 3Y50.95%
EBIT Next 5Y38.1%
FCF growth 1Y770.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2321.04%
OCF growth 3YN/A
OCF growth 5YN/A